Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

被引：0
|
作者：
Carlat, Daniel J. [1 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
PSYCHOPHARMACOLOGY BULLETIN | 2007年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [21] Symptoms of sexual dysfunction in patients treated for major depressive disorder: A meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale
    Clayton, Anita H.
    Campbell, Bryan J.
    Favit, Antonella
    Yang, Ying
    Moonsammy, George
    Piontek, Catherine M.
    Amsterdam, Jay D.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (12) : 1860 - 1866
  • [22] Meta-analysis of placebo rates in major depressive disorder trials
    Stolk, P
    ten Berg, MJ
    Hemels, MEH
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1891 - 1899
  • [23] Efficacy of inpatient psychotherapy for major depressive disorder: a meta-analysis of controlled trials
    Schefft, C.
    Guhn, A.
    Brakemeier, E. -L.
    Sterzer, P.
    Koehler, S.
    ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (04) : 322 - 335
  • [24] The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis
    A DeFelice
    J Willard
    J Lawrence
    J Hung
    M A Gordon
    A Karkowsky
    S Targum
    D C Throckmorton
    J Girton
    B Stertz
    S P Glasser
    R J Lipicky
    Journal of Human Hypertension, 2008, 22 : 659 - 668
  • [25] The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis
    DeFelice, A.
    Willard, J.
    Lawrence, J.
    Hung, J.
    Gordon, M. A.
    Karkowsky, A.
    Targum, S.
    Throckmorton, D. C.
    Girton, J.
    Stertz, B.
    Glasser, S. P.
    Lipicky, R. J.
    JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (10) : 659 - 668
  • [26] Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials
    Swieczkowski, Damian
    Kwasny, Aleksander
    Pruc, Michal
    Gaca, Zuzanna
    Szarpak, Lukasz
    Cubala, Wieslaw J.
    PSYCHIATRY RESEARCH, 2025, 344
  • [27] Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder
    Kornstein, Susan G.
    Jiang, Qin
    Reddy, Sujana
    Musgnung, Jeff J.
    Guico-Pabia, Christine J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (08) : 1088 - 1096
  • [28] Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder
    Kasper, Siegfried
    Montgomery, Stuart A.
    Moeller, Hans-Juergen
    van Oers, Helga J. J.
    Schutte, Albert Jan
    Vrijland, Peter
    van der Meulen, Egbert A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2010, 11 (01): : 36 - 44
  • [29] Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
    Han, Yu
    Chen, Jianjun
    Zou, Dezhi
    Zheng, Peng
    Li, Qi
    Wang, Haiyang
    Li, Pengfei
    Zhou, Xinyu
    Zhang, Yuqing
    Liu, Yiyun
    Xie, Peng
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 2859 - 2867
  • [30] Analysis of the Effect of Desvenlafaxine on Anxiety Symptoms Associated with Major Depressive Disorder: Pooled Data from 9 Short-Term, Double-blind, Placebo-Controlled Trials
    Tourian, Karen A.
    Jiang, Qin
    Ninan, Philip T.
    CNS SPECTRUMS, 2010, 15 (03) : 187 - 193
12345